Lisburn, Ireland

Keith Lorimer

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith Lorimer. Retrieved from https://idiyas.com/inventor/keith-lorimer-f0lqfbsg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Keith Lorimer and His Patent on Rasagiline Citrate

Introduction

Keith Lorimer, an accomplished inventor based in Lisburn, Ireland, has made significant contributions to the pharmaceutical field. With one patent to his name, he continues to be a noteworthy figure in the innovation landscape, particularly in the development of medicinal compounds.

Latest Patents

Lorimer holds a patent for "Dispersions of Rasagiline Citrate." The subject of this invention is a solid dispersion of rasagiline citrate, which includes a composition and a detailed process for its manufacture. This invention holds promise for enhancing the delivery and efficacy of this important medicinal compound.

Career Highlights

Currently, Lorimer is associated with Teva Pharmaceutical Industries Limited, a renowned player in the pharmaceutical industry. His role in the company underscores his commitment to advancing healthcare solutions through innovative inventions.

Collaborations

In his professional journey, Lorimer collaborates with talented individuals such as David Alan Engers. Together, they work towards developing pharmaceutical innovations that can improve patient outcomes and drive progress in the industry.

Conclusion

Keith Lorimer's dedication to innovation in the pharmaceutical sector, exemplified by his patent on rasagiline citrate dispersions, highlights his role as a pivotal inventor. As he continues to collaborate with others in the field, the potential for new breakthroughs in medicine remains promising.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…